Covered recipient · General Payments record
BENJAMIN MORGAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2025
$2,359.92
- Reported across 166 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $416.09 | 33 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $147.14 | 18 |
| Novo Nordisk AS | $55.21 | 3 |
| Ardelyx, Inc. | $42.38 | 2 |
| Xeris Pharmaceuticals, Inc. | $32.75 | 2 |
| Amgen Inc. | $30.31 | 2 |
| Phathom Pharmaceuticals, Inc. | $23.42 | 1 |
| ITI, Inc. | $22.97 | 1 |
| Exact Sciences Corporation | $17.29 | 1 |
| Paratek Pharmaceuticals, Inc. | $15.35 | 1 |
| GlaxoSmithKline, LLC. | $15.27 | 1 |
| Viatris Specialty LLC | $14.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2025 20202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.97 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136351 | CMS |
| ABBVIE INC. | $9.53 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136357 | CMS |
| ABBVIE INC. | $8.33 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136364 | CMS |
| ABBVIE INC. | $13.41 | 03/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136369 | CMS |
| ABBVIE INC. | $1.29 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136375 | CMS |
| ABBVIE INC. | $19.85 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136380 | CMS |
| ABBVIE INC. | $0.88 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136386 | CMS |
| ABBVIE INC. | $8.19 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136392 | CMS |
| ABBVIE INC. | $15.87 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136399 | CMS |
| ABBVIE INC. | $2.89 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136404 | CMS |
| ABBVIE INC. | $15.79 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136410 | CMS |
| ABBVIE INC. | $0.35 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136416 | CMS |
| ABBVIE INC. | $3.17 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136422 | CMS |
| ABBVIE INC. | $1.78 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136429 | CMS |
| ABBVIE INC. | $5.94 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136435 | CMS |
| ABBVIE INC. | $7.42 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136440 | CMS |
| ABBVIE INC. | $14.02 | 12/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136446 | CMS |
| ABBVIE INC. | $13.46 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203136451 | CMS |
| Amgen Inc. | $13.48 | 07/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227229038 | CMS |
| Amgen Inc. | $16.83 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228633118 | CMS |
| Ardelyx, Inc. | $21.10 | 05/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247868842 | CMS |
| Ardelyx, Inc. | $21.28 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247868844 | CMS |
| Exact Sciences Corporation | $17.29 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235640185 | CMS |
| GlaxoSmithKline, LLC. | $15.27 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190431586 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22.97 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241368577 | CMS |
| Novo Nordisk Inc | $14.44 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188638783 | CMS |
| Novo Nordisk Inc | $21.43 | 06/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188869986 | CMS |
| Novo Nordisk Inc | $19.34 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188489809 | CMS |
| Paratek Pharmaceuticals, Inc. | $15.35 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181757018 | CMS |
| Phathom Pharmaceuticals, Inc. | $23.42 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219382511 | CMS |
| Viatris Specialty LLC | $14.00 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238498023 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.57 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250150692 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.18 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250150694 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.